Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving 3-AP together with gemcitabine works in
treating patients with unresectable or metastatic bile duct or gallbladder cancer. Drugs used
in chemotherapy, such as 3-AP and gemcitabine, work in different ways to stop tumor cells
from dividing so they stop growing or die. 3-AP may help gemcitabine kill more cancer cells
by making them more sensitive to the drug.